Hjem › Alzheimers sykdom › Pennsylvania
Kliniske studier for Alzheimers sykdom i Pennsylvania
24 studier for Alzheimers sykdom søker deltakere på steder i Pennsylvania.
Byer i Pennsylvania
Offisiell studietekst (engelsk)
Dominantly Inherited Alzheimer Network (DIAN)
- University of Pittsburgh, Pittsburgh
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 18 og eldre · Alle kjønn · Oppdatert 5. okt. 2026 · NCT00869817A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's Disease
- Flourish Research - Keystone Clinical Studies- Site Number : 8400003, Plymouth Meeting
RekruttererFase 2
Alder 55 til 85 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07688213A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
- Pennsylvania Hospital, Philadelphia
RekruttererFase 2
Alder 55 til 85 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07589595Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- Flourish Research ? Philadelphia, Plymouth Meeting
RekruttererFase 3
Alder 50 til 90 · Alle kjønn · Oppdatert 21. sep. 2026 · NCT07177352PET Imaging Tau Accumulation in FTLD and Atypical Alzheimer's Using [18F]-PI-2620
- Perelman Center for Advance Medicine, Philadelphia
RekruttererFase 3Frivillige helsepersonell ønskes velkommen
Alder 18 og eldre · Alle kjønn · Oppdatert 21. sep. 2026 · NCT05456503A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
- Keystone Clinical Studies, Plymouth Meeting
RekruttererFase 3
Alder 60 til 85 · Alle kjønn · Oppdatert 17. sep. 2026 · NCT06976203Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders
- Hospital of the University of Pennsylvania, Philadelphia
- Allegheny General Hospital, Pittsburgh
Rekrutterer
Alder 70 og eldre · Alle kjønn · Oppdatert 8. sep. 2026 · NCT05929703Tau PET/CT Imaging in the Mismatch Prospective Cohort Study (MPC-TAU)
- University of Pennsylvania, Philadelphia
RekruttererObservasjonsstudie
Alder 18 til 120 · Alle kjønn · Oppdatert 4. sep. 2026 · NCT05658913Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
- Thomas Jefferson University - Vickie & Jack Farber Institute for Neuroscience, Philadelphia
RekruttererFase 2
Alder 55 til 90 · Alle kjønn · Oppdatert 1. sep. 2026 · NCT06808984Biofluid Research on Age-Related or Inherited Neurodegeneration
- University of Pennsylvania, Philadelphia
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 18 og eldre · Alle kjønn · Oppdatert 1. sep. 2026 · NCT07798700A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
- Flourish Research ( Site 1048), Plymouth Meeting
RekruttererFase 2
Alder 50 til 85 · Alle kjønn · Oppdatert 26. aug. 2026 · NCT07033494Using the EHR to Advance Genomic Medicine Across a Diverse Health System
- Penn Medicine, Philadelphia
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 14. aug. 2026 · NCT06377033The Effects of Successful OSA Treatment on Memory and AD Biomarkers in Older Adults Study
- University of Pittsburgh, Pittsburgh
Rekrutterer
Alder 55 til 85 · Alle kjønn · Oppdatert 6. aug. 2026 · NCT05988385Evaluating the Effectiveness of the Health App Recommendation Tool
- University of Pittsburgh, Pittsburgh
RekruttererFrivillige helsepersonell ønskes velkommen
Alder 18 til 65 · Alle kjønn · Oppdatert 6. aug. 2026 · NCT07216716Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- Penn Presbyterian Medical Center, Philadelphia
- University of Pittsburgh Medical Center, Presbyterian Hospital, Pittsburgh
RekruttererFase 3
Alder 18 til 75 · Alle kjønn · Oppdatert 4. aug. 2026 · NCT06563895A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
- University of Pittsburgh, Pittsburgh
RekruttererFase 2/3Frivillige helsepersonell ønskes velkommen
Alder 18 og eldre · Alle kjønn · Oppdatert 27. jul. 2026 · NCT05552157A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
- University of Pittsburgh, Pittsburgh
RekruttererFase 2/3Frivillige helsepersonell ønskes velkommen
Alder 18 og eldre · Alle kjønn · Oppdatert 27. jul. 2026 · NCT06647498Improving Access to Care for Veterans With Memory Loss
- VA Pittsburgh Healthcare System, Pittsburgh
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 17. jul. 2026 · NCT07117162A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
- Abington Neurological Associates Ltd, Willow Grove
RekruttererFase 2
Alder 50 til 85 · Alle kjønn · Oppdatert 26. jun. 2026 · NCT07094516Trial-Ready Cohort-Down Syndrome (TRC-DS)
- University of Pittsburgh, Co-Enrolling through ABC-DS Only, Pittsburgh
RekruttererObservasjonsstudie
Alder 25 til 55 · Alle kjønn · Oppdatert 18. mai 2026 · NCT04165109Late Onset Alzheimer's Disease
- University of Pittsburgh, Pittsburgh
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 55 og eldre · Alle kjønn · Oppdatert 18. mai 2026 · NCT05010603UPenn Observational Research Repository on Neurodegenerative Disease
- University of Pennsylvania, Philadelphia
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 18 og eldre · Alle kjønn · Oppdatert 22. jan. 2026 · NCT04715399Study of Biodistribution, Metabolism, Excretion and Brain Uptake 18F-JSS20-183A
- University of Pennsylvania, Philadelphia
RekruttererTidlig fase 1
Alder 40 til 85 · Alle kjønn · Oppdatert 23. des. 2025 · NCT06932809Impact of a Biophoton Therapy on Patients With Brain Disorders
- Tesla MedBed Center, 139 Pittsburgh Road, Butler, PA 16001, Butler
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 8. aug. 2025 · NCT06147999Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.